Literature DB >> 19968661

Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up.

Kerri M Clough-Gorr1, Patricia A Ganz, Rebecca A Silliman.   

Abstract

Lymphedema of the arm is a common complication of breast cancer with symptoms that can persist over long periods of time. For older women (over 50% of breast cancer cases) it means living with the potential for long-term complications of persistent lymphedema in conjunction with the common diseases and disabilities of aging over survivorship. We identified women > or =65 years diagnosed with primary stage I-IIIA breast cancer. Data were collected over 7 years of follow-up from consenting patients' medical records and telephone interviews. Data collected included self-reported symptoms of persistent lymphedema, breast cancer characteristics, and selected sociodemographic and health-related characteristics. The overall prevalence of symptoms of persistent lymphedema was 36% over 7 years of follow-up. Having stage II or III (OR = 1.77, 95% CI: 1.07-2.93) breast cancer and having a BMI >30 (OR = 3.04, 95% CI: 1.69-5.45) were statistically significantly predictive of symptoms of persistent lymphedema. Women > or =80 years were less likely to report symptoms of persistent lymphedema when compared to younger women (OR = 0.44, 95% CI: 0.18-0.95). Women with symptoms of persistent lymphedema consistently reported worse general mental health and physical function. Symptoms of persistent lymphedema were common in this population of older breast cancer survivors and had a noticeable effect on both physical function and general mental health. Our findings provide evidence of the impact of symptoms of persistent lymphedema on the quality of survivorship of older women. Clinical and research efforts focused on risk factors for symptoms of persistent lymphedema in older breast cancer survivors may lead to preventative and therapeutic measures that help maintain their health and well-being over increasing periods of survivorship.

Entities:  

Mesh:

Year:  2009        PMID: 19968661      PMCID: PMC2873157          DOI: 10.1111/j.1524-4741.2009.00878.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  56 in total

1.  Development and validation of a telephone questionnaire to characterize lymphedema in women treated for breast cancer.

Authors:  S A Norman; L T Miller; H B Erikson; M F Norman; R McCorkle
Journal:  Phys Ther       Date:  2001-06

2.  The psychological impact of post-operative arm morbidity following axillary surgery for breast cancer: a critical review.

Authors:  K Poole; L J Fallowfield
Journal:  Breast       Date:  2002-02       Impact factor: 4.380

3.  Life after breast cancer: understanding women's health-related quality of life and sexual functioning.

Authors:  P A Ganz; J H Rowland; K Desmond; B E Meyerowitz; G E Wyatt
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

Review 4.  Arm edema in breast cancer patients.

Authors:  V S Erickson; M L Pearson; P A Ganz; J Adams; K L Kahn
Journal:  J Natl Cancer Inst       Date:  2001-01-17       Impact factor: 13.506

Review 5.  Lymphedema: current issues in research and management.

Authors:  J A Petrek; P I Pressman; R A Smith
Journal:  CA Cancer J Clin       Date:  2000 Sep-Oct       Impact factor: 508.702

6.  Lymphedema: Knowledge, Treatment, and Impact Among Breast Cancer Survivors.

Authors:  Electra D. Paskett; Nancy Stark
Journal:  Breast J       Date:  2000-11       Impact factor: 2.431

7.  Breast cancer-related lymphedema--what are the significant predictors and how they affect the severity of lymphedema?

Authors:  Atilla Soran; Gina D'Angelo; Mirsada Begovic; Figen Ardic; Ali Harlak; H Samuel Wieand; Victor G Vogel; Ronald R Johnson
Journal:  Breast J       Date:  2006 Nov-Dec       Impact factor: 2.431

8.  Factors associated with increased breast cancer-related lymphedema volume.

Authors:  Stephane Vignes; Maria Arrault; Alain Dupuy
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

9.  Two-step axillary operation increases risk of arm morbidity in breast cancer patients.

Authors:  M Husen; B Paaschburg; H L Flyger
Journal:  Breast       Date:  2006-03-02       Impact factor: 4.380

10.  Lymphedema after treatment of breast cancer.

Authors:  Cihangir Ozaslan; Bekir Kuru
Journal:  Am J Surg       Date:  2004-01       Impact factor: 2.565

View more
  11 in total

1.  Quality of life among a population-based cohort of older patients with breast cancer.

Authors:  Joan M Neuner; Nathan Zokoe; Emily L McGinley; Liliana E Pezzin; Tina W F Yen; Marilyn M Schapira; Ann B Nattinger
Journal:  Breast       Date:  2014-07-14       Impact factor: 4.380

Review 2.  Risk Factors Associated with Lymphedema among Postmenopausal Breast Cancer Survivors after Radical Mastectomy and Axillary Dissection in China.

Authors:  Huang Hua-Ping; Zhou Jian-Rong; Qing Zeng
Journal:  Breast Care (Basel)       Date:  2012-12       Impact factor: 2.860

3.  Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.

Authors:  Daniella M F Paiva; Vivian O Rodrigues; Marcelle G Cesca; Pamella V Palma; Isabel C G Leite
Journal:  BMC Womens Health       Date:  2013-02-13       Impact factor: 2.809

4.  Perspectives of the Breast Cancer Survivorship Continuum: Diagnosis through 30 Months Post-Treatment.

Authors:  Jennifer M Hulett; Jane M Armer; Bob R Stewart; Ausanee Wanchai
Journal:  J Pers Med       Date:  2015-05-28

5.  Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.

Authors:  Kayo Togawa; Huiyan Ma; Jane Sullivan-Halley; Marian L Neuhouser; Ikuyo Imayama; Kathy B Baumgartner; Ashley Wilder Smith; Catherine M Alfano; Anne McTiernan; Rachel Ballard-Barbash; Leslie Bernstein
Journal:  Breast Cancer Res       Date:  2014-08-22       Impact factor: 6.466

Review 6.  Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies.

Authors:  D S M Chan; A R Vieira; D Aune; E V Bandera; D C Greenwood; A McTiernan; D Navarro Rosenblatt; I Thune; R Vieira; T Norat
Journal:  Ann Oncol       Date:  2014-04-27       Impact factor: 32.976

7.  Exercise barriers self-efficacy: development and validation of a subcale for individuals with cancer-related lymphedema.

Authors:  Jena Buchan; Monika Janda; Robyn Box; Laura Rogers; Sandi Hayes
Journal:  Health Qual Life Outcomes       Date:  2015-03-18       Impact factor: 3.186

Review 8.  A Systematic Review of Spiritually Based Interventions and Psychoneuroimmunological Outcomes in Breast Cancer Survivorship.

Authors:  Jennifer M Hulett; Jane M Armer
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

9.  Integrating Symptoms Into the Diagnostic Criteria for Breast Cancer-Related Lymphedema: Applying Results From a Prospective Surveillance Program.

Authors:  Cheryl L Brunelle; Sacha A Roberts; Nora K Horick; Tessa C Gillespie; Jamie M Jacobs; Kayla M Daniell; George E Naoum; Alphonse G Taghian
Journal:  Phys Ther       Date:  2020-12-07

Review 10.  Lymphoedema After Breast Cancer Treatment is Associated With Higher Body Mass Index: A Systematic Review and Meta-Analysis.

Authors:  Astère Manirakiza; Laurent Irakoze; Lin Shui; Sébastien Manirakiza; Louis Ngendahayo
Journal:  East Afr Health Res J       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.